A Single-Arm Phase 2 Trial on Induction Chemotherapy Followed by Concurrent Chemoradiation in Nasopharyngeal Carcinoma Using a Reduced Cumulative Dose of Cisplatin

Overview of attention for article published in Frontiers in oncology, April 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

twitter: 2 X users

Readers on

mendeley: 3 Mendeley

Summary X

So far, Altmetric has seen 3 X posts from 2 X users, with an upper bound of 6,756 followers.

New research: A Single-Arm Phase 2 Trial on Induction Chemotherapy Followed by Concurrent Chemoradiation in Nasopharyngeal Carcinoma Using a Reduced Cumulative Dose of Cisplatin: Background We conducted this study to evaluate if a reduced… https://t.co/9h

27 Apr 2022

Reply Repost Favourite

RT @AyaHelali: Excited to share our recent trial demonstrating that reduced cumulative cisplatin in PX induction chemotherapy and CCRT in L…

27 Apr 2022

Reply Repost Favourite

Excited to share our recent trial demonstrating that reduced cumulative cisplatin in PX induction chemotherapy and CCRT in LA NPC was non-inferior to the corresponding arm in the NPC-501 trial. ⁦@FrontOncology⁩ ⁦@hkumed⁩ #HKUShenzhenHospital https://t.co/

27 Apr 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.